Soluble cortex | Soluble hippocampus | |||||
---|---|---|---|---|---|---|
RZ3 | CP13 | PHF1 | RZ3 | CP13 | PHF1 | |
Effect size (95% CI) | Effect size (95% CI) | |||||
Immediately after AN | ||||||
COMTKO/P301L (n per group = 8, 10) | 0.060 (− 0.87,0.99) | 3.57* (2.08,5.07) | 1.52* (0.46,2.57) | 0.48 (− 0.46,1.42) | 1.65* (0.57,2.72) | 2.85* (1.53,4.16) |
P301L (n per group = 8, 8/7) | 1.12* (0.06,2.17) | 3.17* (1.65,4.69) | 1.01 (− 0.03,2.06) | 0.98 (− 0.09,2.06) | 1.38* (0.25,2.51) | 2.26* (0.97,3.56) |
24 h after AN | ||||||
COMTKO/P301L (n per group = 8, 8) | − 2.07* (− 3.28,− 0.86) | − 0.38 (− 1.37,0.61) | − 1.20* (− 2.27,− 0.14) | − 0.30 (− 1.28,0.69) | − 0.15 (− 1.13,0.83) | − 0.10 (− 1.08,0.89) |
P301L (n per group = 8, 8/7) | − 1.00 (− 2.04,0.04) | 1.11* (0.05,2.16) | − 0.07 (− 1.05,0.92) | − 0.08 (− 1.09,0.94) | − 0.15 (− 1.16,0.87) | 0.52 (− 0.48,1.52) |